93 related articles for article (PubMed ID: 23127337)
1. Psf3 is a prognostic biomarker in lung adenocarcinoma.
Hokka D; Maniwa Y; Tane S; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Sakai Y; Chen X; Hayashi Y
Lung Cancer; 2013 Jan; 79(1):77-82. PubMed ID: 23127337
[TBL] [Abstract][Full Text] [Related]
2. Psf3 is a prognostic biomarker in lung adenocarcinoma: a larger trial using tissue microarrays of 864 consecutive resections.
Tauchi S; Sakai Y; Fujimoto S; Ogawa H; Tane S; Hokka D; Tanaka Y; Nishio W; Yoshimura M; Yanagita E; Itoh T; Hayashi Y; Maniwa Y
Eur J Cardiothorac Surg; 2016 Oct; 50(4):758-764. PubMed ID: 27005977
[TBL] [Abstract][Full Text] [Related]
3. Partner of Sld five 3: a potential prognostic biomarker for colorectal cancer.
Sun X; Sui W; Huang M; Wang Y; Xuan Y; Wang Z
Diagn Pathol; 2014 Nov; 9():217. PubMed ID: 25403684
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of GINS complex in colorectal cancer].
Wei HB; Wen JZ; Wei B; Han XY; Zhang S
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jun; 14(6):443-7. PubMed ID: 21713706
[TBL] [Abstract][Full Text] [Related]
5. PSF3 marks malignant colon cancer and has a role in cancer cell proliferation.
Nagahama Y; Ueno M; Haraguchi N; Mori M; Takakura N
Biochem Biophys Res Commun; 2010 Feb; 392(2):150-4. PubMed ID: 20059967
[TBL] [Abstract][Full Text] [Related]
6. Psf3 as a possible biomarker of postoperative chemotherapy for patients with early pulmonary adenocarcinoma.
Kimura K; Tanaka Y; Tauchi S; Kitamura Y; Nishio W; Sakai Y; Hayashi Y; Yoshimura M; Maniwa Y
Thorac Cancer; 2019 Dec; 10(12):2300-2307. PubMed ID: 31637868
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics.
Sterlacci W; Tzankov A; Veits L; Oberaigner W; Schmid T; Hilbe W; Fiegl M
Am J Clin Pathol; 2011 Apr; 135(4):611-8. PubMed ID: 21411784
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of centromere protein A in human lung adenocarcinoma.
Wu Q; Qian YM; Zhao XL; Wang SM; Feng XJ; Chen XF; Zhang SH
Lung Cancer; 2012 Aug; 77(2):407-14. PubMed ID: 22542705
[TBL] [Abstract][Full Text] [Related]
9. Expression of the transient receptor potential channel c3 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.
Saito H; Minamiya Y; Watanabe H; Takahashi N; Ito M; Toda H; Konno H; Mitsui M; Motoyama S; Ogawa J
Ann Surg Oncol; 2011 Nov; 18(12):3377-83. PubMed ID: 21603869
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of clusterin in resected adenocarcinomas of the lung.
Panico F; Casali C; Rossi G; Rizzi F; Morandi U; Bettuzzi S; Davalli P; Corbetta L; Storelli ES; Corti A; Fabbri LM; Astancolle S; Luppi F
Lung Cancer; 2013 Mar; 79(3):294-9. PubMed ID: 23276503
[TBL] [Abstract][Full Text] [Related]
11. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of PSF3 expression in uterine endometrial carcinomas.
Park JK; Otsuka N; Tomaru U; Suzuki H; Azuma M; Okamoto K; Yamashiro K; Kasahara M
Hum Pathol; 2018 Oct; 80():104-112. PubMed ID: 29936059
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
[TBL] [Abstract][Full Text] [Related]
15. Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung.
Minamiya Y; Ono T; Saito H; Takahashi N; Ito M; Mitsui M; Motoyama S; Ogawa J
Lung Cancer; 2011 Nov; 74(2):300-4. PubMed ID: 21466904
[TBL] [Abstract][Full Text] [Related]
16. High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer.
Sterlacci W; Wolf D; Savic S; Hilbe W; Schmid T; Jamnig H; Fiegl M; Tzankov A
Hum Pathol; 2012 Mar; 43(3):339-49. PubMed ID: 21840566
[TBL] [Abstract][Full Text] [Related]
17. MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications.
Hashimoto K; Araki K; Osaki M; Nakamura H; Tomita K; Shimizu E; Ito H
Pathobiology; 2004; 71(4):193-200. PubMed ID: 15263808
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma.
Narahashi T; Niki T; Wang T; Goto A; Matsubara D; Funata N; Fukayama M
Histopathology; 2006 Oct; 49(4):349-57. PubMed ID: 16978197
[TBL] [Abstract][Full Text] [Related]
19. Micropapillary lung adenocarcinoma: a distinctive histologic subtype with prognostic significance. Case series.
Sánchez-Mora N; Presmanes MC; Monroy V; Moreno N; Lara-Martínez JM; Aladro MH; Alvarez-Fernández E
Hum Pathol; 2008 Mar; 39(3):324-30. PubMed ID: 18261622
[TBL] [Abstract][Full Text] [Related]
20. High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.
Anagnostou VK; Bepler G; Syrigos KN; Tanoue L; Gettinger S; Homer RJ; Boffa D; Detterbeck F; Rimm DL
Clin Cancer Res; 2009 Jun; 15(12):4157-64. PubMed ID: 19509151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
